98 related articles for article (PubMed ID: 7772242)
21. Kangaroo IGF-II is structurally and functionally similar to the human [Ser29]-IGF-II variant.
Yandell CA; Francis GL; Wheldrake JF; Upton Z
J Endocrinol; 1999 Jun; 161(3):445-53. PubMed ID: 10333547
[TBL] [Abstract][Full Text] [Related]
22. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency.
Francis GL; Ross M; Ballard FJ; Milner SJ; Senn C; McNeil KA; Wallace JC; King R; Wells JR
J Mol Endocrinol; 1992 Jun; 8(3):213-23. PubMed ID: 1378742
[TBL] [Abstract][Full Text] [Related]
23. Recombinant canine single chain insulin analogues: insulin receptor binding capacity and ability to stimulate glucose uptake.
Adams JP; Holder AL; Catchpole B
Vet J; 2014 Dec; 202(3):436-42. PubMed ID: 25457265
[TBL] [Abstract][Full Text] [Related]
24. Expression, purification and binding to the receptor of human insulin-like growth factor II.
Miyagishima T; Gasa S; Honke K; Sakai M; Nishi S; Yamamoto M; Nishikawa K; Miyazaki T; Makita A
Biochim Biophys Acta; 1993 Nov; 1203(1):155-61. PubMed ID: 8218385
[TBL] [Abstract][Full Text] [Related]
25. Purification and refolding of recombinant human IGF II from silkworms infected with recombinant Bombyx mori nuclear polyhedrosis virus.
Marumoto Y; Teruuchi T; Enjoh T; Numata F; Sakano K
Biosci Biotechnol Biochem; 1992 Jan; 56(1):13-6. PubMed ID: 1368125
[TBL] [Abstract][Full Text] [Related]
26. Characterization of an extended form of recombinant human insulin-like growth factor II.
Hammarberg B; Tally M; Samuelsson E; Wadensten H; Holmgren E; Hartmanis M; Hall K; Uhlén M; Moks T
J Biol Chem; 1991 Jun; 266(17):11058-62. PubMed ID: 1645723
[TBL] [Abstract][Full Text] [Related]
27. Mutants of human insulin-like growth factor II: expression and characterization of analogs with a substitution of TYR27 and/or a deletion of residues 62-67.
Roth BV; Bürgisser DM; Lüthi C; Humbel RE
Biochem Biophys Res Commun; 1991 Dec; 181(2):907-14. PubMed ID: 1721812
[TBL] [Abstract][Full Text] [Related]
28. Purification, partial sequences and properties of chicken insulin-like growth factors.
Dawe SR; Francis GL; McNamara PJ; Wallace JC; Ballard FJ
J Endocrinol; 1988 May; 117(2):173-81. PubMed ID: 3379351
[TBL] [Abstract][Full Text] [Related]
29. Mutations at positions 11 and 60 of insulin-like growth factor 1 reveal differences between its interactions with the type I insulin-like-growth-factor receptor and the insulin receptor.
Hodgson DR; May FE; Westley BR
Eur J Biochem; 1995 Oct; 233(1):299-309. PubMed ID: 7588759
[TBL] [Abstract][Full Text] [Related]
30. Assessment of developmental changes in chicken and turkey insulin-like growth factor-II by homologous radioimmunoassay.
McMurtry JP; Rosebrough RW; Brocht DM; Francis GL; Upton Z; Phelps P
J Endocrinol; 1998 Jun; 157(3):463-73. PubMed ID: 9691979
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II.
Francis GL; Aplin SE; Milner SJ; McNeil KA; Ballard FJ; Wallace JC
Biochem J; 1993 Aug; 293 ( Pt 3)(Pt 3):713-9. PubMed ID: 7688957
[TBL] [Abstract][Full Text] [Related]
32. Expression and purification of recombinant insulin-like growth factors from Escherichia coli.
Nilsson B; Forsberg G; Hartmanis M
Methods Enzymol; 1991; 198():3-16. PubMed ID: 1857223
[No Abstract] [Full Text] [Related]
33. Production of bovine insulin-like growth factor 2 (bIGF2) in Escherichia coli.
Easton AM; Gierse JK; Seetharam R; Klein BK; Kotts CE
Gene; 1991 May; 101(2):291-5. PubMed ID: 2055493
[TBL] [Abstract][Full Text] [Related]
34. Mutants of human insulin-like growth factor II (IGF II). Expression and characterization of truncated IGF II and of two naturally occurring variants.
Lüthi C; Roth BV; Humbel RE
Eur J Biochem; 1992 Apr; 205(2):483-90. PubMed ID: 1374027
[TBL] [Abstract][Full Text] [Related]
35. Purification, amino acid sequence and characterisation of kangaroo IGF-I.
Yandell CA; Francis GL; Wheldrake JF; Upton Z
J Endocrinol; 1998 Jan; 156(1):195-204. PubMed ID: 9496249
[TBL] [Abstract][Full Text] [Related]
36. Human insulin-like growth factor I (IGF-I) produced in the mammary glands of transgenic rabbits: yield, receptor binding, mitogenic activity, and effects on IGF-binding proteins.
Wolf E; Jehle PM; Weber MM; Sauerwein H; Daxenberger A; Breier BH; Besenfelder U; Frenyo L; Brem G
Endocrinology; 1997 Jan; 138(1):307-13. PubMed ID: 8977418
[TBL] [Abstract][Full Text] [Related]
37. High-level expression and simple purification of recombinant human insulin-like growth factor I.
Kim SO; Lee YI
J Biotechnol; 1996 Jul; 48(1-2):97-105. PubMed ID: 8818276
[TBL] [Abstract][Full Text] [Related]
38. Purification, amino acid sequences and assay cross-reactivities of porcine insulin-like growth factor-I and -II.
Francis GL; Owens PC; McNeil KA; Wallace JC; Ballard FJ
J Endocrinol; 1989 Sep; 122(3):681-7. PubMed ID: 2809477
[TBL] [Abstract][Full Text] [Related]
39. High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials.
Frankel AE; Ramage J; Latimer A; Feely T; Delatte S; Hall P; Tagge E; Kreitman R; Willingham M
Protein Expr Purif; 1999 Jun; 16(1):190-201. PubMed ID: 10336877
[TBL] [Abstract][Full Text] [Related]
40. Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II molecule.
Oh Y; Beukers MW; Pham HM; Smanik PA; Smith MC; Rosenfeld RG
Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):249-54. PubMed ID: 1715685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
